欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Macozinone_1377239-83-2_产品详情
1377239-83-2
  • names:

    Macozinone

  • CAS号:

    1377239-83-2

    MDL Number:
  • MF(分子式): C20H23F3N4O3S MW(分子量): 456.48
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Macozinone
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM000097-5mg 5mg 99.13% ¥ 1560.00 ¥ 1560.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 1377239-83-2
Inchi
InchiKey
分子式 Formula C20H23F3N4O3S
分子量 Molecular Weight 456.48
溶解度Solubility 生物体外In Vitro:DMSO溶解度6.4 mg/mL(14.02 mM;Need ultrasonic)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
Macozinone(CAS:1377239-83-2)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 Macozinone (PBTZ169) 是一种有效的杀菌型苯并噻嗪酮,也为有效的DprE1抑制剂
IntroductionMacozinone (PBTZ169) is a bactericidal benzothiazinone and a potentDprE1(decaprenylphosphorylibose 2′xidase) inhibitor. Macozinone inhibits the essential flavoprotein DprE1 by forming a covalent bond with the activeite Cys387 residue. Macozinone has antituberculosis effect[2].
Application1
Application2
Application3
Macozinone (PBTZ169) 是一种有效的杀菌型苯并噻嗪酮,也为有效的DprE1抑制剂。Macozinone 可通过与活性位点 Cys387 残基形成共价键来抑制必需的黄素蛋白 DprE1。Macozinone 有抗结核作用。Macozinone (PBTZ169) is a bactericidal benzothiazinone and a potentDprE1(decaprenylphosphoryl-β-d-ribose 2′-oxidase) inhibitor. Macozinone inhibits the essential flavoprotein DprE1 by forming a covalent bond with the active-site Cys387 residue. Macozinone has antituberculosis effect[1][2].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.
【3】 Makarov V et al. Towards a new combination therapy for tuberculosis with next generation benzothiazinones. EMBO Mol Med. 2014 Mar;6(3):372-83.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents